Jubilant Ingrevia Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹1,394 Cr +24.4% YoYSee revenue, profit and what management said. You are viewing Q3 FY26.
JI

Jubilant Ingrevia Ltd

Q3 FY26Chemicals & Petrochemicals

Jubilant Ingrevia Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹1,051Cr
−0.6% YoY
−6.2% QoQ
Net profit
₹47Cr
−31.9% YoY
−31.9% QoQ
Margin
12%
−1 pp YoY
0 pp QoQ
Price₹718
Market cap₹11.7K Cr
P/E36.9

The short version

Specialty Chemicals volume growth has been double-digit over the past years, expected to continue. Specialty Chemicals segment aims for at least 20% CAGR EBITDA growth over a multi-year horizon, maintaining stable EBITDA margins around 25-26%.

From Jubilant Ingrevia Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Specialty Chemicals volume growth has been double-digit over the past years, expected to continue.
  • Pricing has bottomed out recently, with signs of marginal price increases in some segments.
  • FY '27 is considered a pivotal year to fill new capacity, including the new CDMO agro plant, with significant volume growth expected.
  • 16 molecules confirmed with peak potential of INR1,400 crore; 80+ molecules in pipeline, implying future revenue growth over 3-4 years.
  • Nutritional & Health Solutions showed volume growth; cosmetic grade and food grade products maintain steady growth.
  • CDMO agro project shipment to start March 2026, with scaling expected in FY '27 and beyond.

2 more points from Jubilant Ingrevia Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Jubilant Ingrevia Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Year-to-date capex of INR366 crore primarily spent on the upcoming CDMO agro plant at Bharuch and new multipurpose facility at Gajraula.
  • Planned capex of approximately INR500 crore in FY 2027, funded mainly through internal accruals.
  • Commissioned a new boiler at Bharuch site in Q3 FY '26 to enhance operational efficiency.
  • Agro innovator project commissioning on track, expected to start dispatching volumes from March 2026.
  • Construction commenced on a new multipurpose plant at Gajraula to add flexibility and capacity to CDMO and fine chemicals portfolio.

2 more points from Jubilant Ingrevia Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Jubilant Ingrevia Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Jubilant Ingrevia has an expanded opportunity funnel of over 100 active CDMO opportunities with a peak annual revenue potential of approximately INR 3,500 crore.
  • In the past year, more than 16 molecules have been confirmed with an estimated peak potential of INR 1,400 crore.
  • Advanced discussions are ongoing for over 7 additional opportunities valued at around INR 900 crore.
  • The CDMO contracts have visibility for the first few months and shipments for a large agrochemical order are expected to start by mid-March FY '26.

2 more points from Jubilant Ingrevia Ltd's call on order book

Create a free account to keep reading this call

Jubilant Ingrevia Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Jubilant Ingrevia Ltd Q3 FY26 results — key figures

Jubilant Ingrevia Ltd Q3 FY26 reported results vs Q3 FY25, ₹ crore
₹ CrQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue1,0511,057-0.6%1,121-6.2%
Operating profit (EBITDA)126138-8.7%135-6.7%
Operating margin12%13%-1 pp12%0 pp
Profit before tax6596-32.3%93-30.1%
Net profit (PAT)4769-31.9%69-31.9%
EPS (₹)2.944.36-32.6%4.36-32.6%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.4K Cr, net profit ₹111 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Neochem Bio (Q3 FY26)

    Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and

  • Thirumalai Chemicals (Q3 FY26)

    Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran

  • IVP (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector

  • Gujarat Alkalies (Q3 FY26)

    3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Jubilant Ingrevia Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Jubilant Ingrevia Ltd Q3 FY26 results?

Specialty Chemicals volume growth has been double-digit over the past years, expected to continue. Specialty Chemicals segment aims for at least 20% CAGR EBITDA growth over a multi-year horizon, maintaining stable EBITDA margins around 25-26%.

What is Jubilant Ingrevia Ltd share price analysis?

Jubilant Ingrevia Ltd currently shows a neutral. The stock trades at a P/E of 36.9 with a market cap of ₹11,738 Cr. Investors should review the full earnings analysis for detailed insights.

Is Jubilant Ingrevia Ltd planning capital expenditure?

Year-to-date capex of INR366 crore primarily spent on the upcoming CDMO agro plant at Bharuch and new multipurpose facility at Gajraula.

Keep Jubilant Ingrevia Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.